tiprankstipranks
Trending News
More News >
Io Biotech, Inc. (IOBT)
NASDAQ:IOBT
US Market

IO Biotech (IOBT) Income Statement

Compare
456 Followers

IO Biotech Income Statement

Last quarter (Q3 2025), IO Biotech's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, IO Biotech's net income was $-8.38M. See IO Biotech’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -849.00K$ -756.00K$ -540.00K$ 0.00$ 0.00
Operating Expenses
$ 94.33M$ 90.69M$ 70.88M$ 41.23M$ 10.14M
Depreciation and Amortization
$ 849.00K$ 756.00K$ 540.00K$ 2.00K$ 0.00
EBITDA
$ -93.20M$ -84.47M$ -69.34M$ -67.45M$ -12.02M
Operating Income
$ -95.18M$ -91.44M$ -71.42M$ -41.23M$ -10.14M
Other Income/Expenses
$ 1.13M$ 6.21M$ 1.24M$ -26.58M$ -1.90M
Pretax Income
$ -94.05M$ -85.23M$ -70.19M$ -67.81M$ -12.04M
Net Income
$ -95.49M$ -86.08M$ -71.46M$ -67.88M$ -12.04M
Per Share Metrics
Basic EPS
$ -1.45$ -1.98$ -2.48$ -2.36$ -1.05
Diluted EPS
$ -1.45$ -1.98$ -2.48$ -2.36$ -1.05
Weighted Average Shares Outstanding
65.88M 43.54M 28.82M 28.82M 11.55M
Weighted Average Shares Outstanding (Diluted)
65.88M 43.54M 28.82M 28.82M 11.55M
Currency in USD

IO Biotech Earnings and Revenue History